Sage Therapeutics Inc (SAGE)
6.05
-0.03
(-0.49%)
USD |
NASDAQ |
Nov 01, 16:00
6.047
0.00 (0.00%)
After-Hours: 20:00
Sage Therapeutics Revenue (Quarterly): 11.87M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 11.87M |
| June 30, 2024 | 8.654M |
| March 31, 2024 | 7.902M |
| December 31, 2023 | 77.97M |
| September 30, 2023 | 2.716M |
| June 30, 2023 | 2.474M |
| March 31, 2023 | 3.294M |
| December 31, 2022 | 2.865M |
| September 30, 2022 | 1.739M |
| June 30, 2022 | 1.501M |
| March 31, 2022 | 1.582M |
| December 31, 2021 | 1.642M |
| September 30, 2021 | 1.44M |
| Date | Value |
|---|---|
| June 30, 2021 | 1.643M |
| March 31, 2021 | 1.583M |
| December 31, 2020 | 1.109B |
| September 30, 2020 | 1.639M |
| June 30, 2020 | 1.089M |
| March 31, 2020 | 2.286M |
| December 31, 2019 | 1.96M |
| September 30, 2019 | 3.57M |
| June 30, 2019 | 0.873M |
| March 31, 2019 | 0.465M |
| December 31, 2018 | 0.273M |
| September 30, 2018 | |
| June 30, 2018 | 90.00M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.089M
Minimum
Jun 2020
1.109B
Maximum
Dec 2020
62.25M
Average
2.123M
Median
Revenue (Quarterly) Benchmarks
| Outset Medical Inc | 27.39M |
| Biogen Inc | 2.466B |
| Johnson & Johnson | 22.47B |
| Lifecore Biomedical Inc | 24.70M |
| Organon & Co | 1.582B |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -93.55M |
| Total Expenses (Quarterly) | 113.07M |
| EPS Diluted (Quarterly) | -1.53 |
| Enterprise Value | -199.06M |
| Gross Profit Margin (Quarterly) | 55.54% |
| Profit Margin (Quarterly) | -788.1% |
| Earnings Yield | -92.07% |
| Normalized Earnings Yield | -92.12 |